Immune-Based Combinations Are Reshaping Liver Cancer Treatment
Dr. Augusto Villanueva Rodriguez, medical director of the Liver Cancer Program at NYU Langone Health, explained that treatment for liver...
cancer
IceCure ProSense Receives Swissmedic Approval for Breast Cancer
This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and Drug...
Post-IO Curative Treatment Conversion May Prolong Survival in Liver Cancer
Curative treatment conversion (CTC), although infrequent, correlated with significantly improved survival in patients who received prior immunotherapy for hepatocellular carcinoma...
HKUMed: Gut Bacterium Hinders Liver Cancer Treatment
A research team led by the Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty...
Novant Health Cancer Institute introduces next-generation treatment for liver cancer | Novant Health
See pictures and video here with access code - Histotripsy_NHFMC_1 WINSTON-SALEM, N.C. – Novant Health is the first healthcare system in...
Liver Cancer Drug Market Demand and Innovations
Table of Content Liver Cancer Drug Market Revenue and Trends 2025 to 2033 The global liver cancer drug market revenue...
